Nexfill volume and RHA1 Teoxane are both popular dermal fillers used in lower face treatments, but they differ in composition, intended use, and application technique. Nexfill volume is a hyaluronic acid-based filler designed to provide volume and support, making it suitable for patients looking to enhance their facial contours. On the other hand, RHA1 Teoxane is part of the Resilient Hyaluronic Acid (RHA) range, which is tailored for dynamic facial movements, offering a more natural look in areas with frequent motion.
Composition and Consistency
Nexfill volume is formulated with cross-linked hyaluronic acid, providing a dense consistency ideal for adding volume and structure to the lower face. Its formulation is designed to integrate smoothly into the skin, delivering a natural and long-lasting result. RHA1 Teoxane, however, utilises resilient hyaluronic acid technology, which allows for flexibility and adaptability to facial movements. This makes it particularly effective in areas where facial expressions are common, ensuring that the appearance remains natural even during movement.
Target Areas and Applications
While both products can be used for lower face treatments, they cater to different aesthetic goals. Nexfill volume is often chosen for its volumising properties, making it suitable for patients who desire pronounced enhancements in areas such as the cheeks and jawline. The filler’s ability to provide support and lift makes it a preferred choice for those seeking to improve facial symmetry and contour. RHA1 Teoxane, on the other hand, is ideal for finer lines and wrinkles, particularly around the mouth and nasolabial folds, where flexibility is crucial to maintaining a natural appearance.
Longevity and Results
Patients considering dermal fillers often factor in the longevity of results. Nexfill volume typically offers results lasting from six to twelve months, depending on the individual’s metabolism and the area treated. The dense structure of the filler ensures that the effects remain visible for an extended period. RHA1 Teoxane, with its unique formulation, provides results that can last up to twelve months as well. The longevity of RHA1 is attributed to its ability to move with facial expressions, reducing the risk of breakdown due to mechanical stress.
Both Nexfill volume and RHA1 Teoxane are designed to enhance the lower face, but they are suited to different treatment goals. Nexfill volume is ideal for patients seeking to enhance volume and contour, offering a robust solution for areas requiring structural support. This makes it a popular choice for enhancing cheekbones and jawlines, where a more defined shape is desired.
In contrast, RHA1 Teoxane is tailored for dynamic areas of the face, where natural movement is frequent. Its resilient hyaluronic acid composition allows it to adapt seamlessly to facial expressions, making it suitable for treating fine lines and wrinkles without compromising the natural look of the skin.
Ultimately, the choice between Nexfill volume and RHA1 Teoxane should be guided by the specific treatment objectives and the desired outcome. Both fillers offer unique benefits, catering to different aspects of facial aesthetics, ensuring that patients receive the most appropriate treatment for their individual needs.
